Goodson R L
Sanofi Winthrop, Inc., New York, New York 10016, USA.
Qual Assur. 1995 Mar;4(1):60-7.
Clinical quality assurance has its roots in the evolution of the GCPs. Historically, the fundamental elements of GCPs provided a springboard to develop and refine a paradigm of standard measurements to assure the integrity and quality of research. The research community spontaneously responded by voluntarily establishing quality assurance units and implementing auditing functions to ensure the highest standards in an industry that encompasses science, medicine, and ethics. Although clinical quality assurance is still unregulated in the United States, the performance of good clinical practices has become an integral part of the clinical research process and has impacted the research community on worldwide basis. The establishment of the EC guidelines, the WHO guidelines, and the International Conference on Harmonization are testaments to the increasing emphasis on the future of GCP-related activities.
临床质量保证源于药物临床试验规范(GCPs)的演变。从历史上看,GCPs的基本要素为开发和完善标准测量范式提供了跳板,以确保研究的完整性和质量。研究界自发做出回应,通过自愿设立质量保证单位并实施审计职能,以确保这个涵盖科学、医学和伦理的行业达到最高标准。尽管在美国临床质量保证仍未得到规范,但良好临床实践的执行已成为临床研究过程不可或缺的一部分,并在全球范围内对研究界产生了影响。欧洲委员会指南、世界卫生组织指南以及国际协调会议的设立,证明了对GCP相关活动未来的重视日益增加。